Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17655
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVoskoboynik, Mark-
dc.contributor.authorMar, Victoria-
dc.contributor.authorMailer, Sonia-
dc.contributor.authorColebatch, Andrew-
dc.contributor.authorFennessy, Anne-
dc.contributor.authorLogan, Aleksandra-
dc.contributor.authorHewitt, Chelsee-
dc.contributor.authorCebon, Jonathan S-
dc.contributor.authorKelly, John-
dc.contributor.authorMcArthur, Grant-
dc.date2016-01-17-
dc.date.accessioned2018-05-02T23:37:07Z-
dc.date.available2018-05-02T23:37:07Z-
dc.date.issued2016-03-
dc.identifier.citationPigment cell & melanoma research 2016; 29(2): 222-8-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17655-
dc.description.abstractBRAF mutations at codons L597 and K601 occur uncommonly in melanoma. Clinical and pathological associations of these mutations were investigated in a cohort of 1119 patients with known BRAF mutation status. A BRAF mutation was identified in 435 patients; Mutations at L597 and the K601E mutation were seen in 3.4 and 3.2% of these, respectively. K601E melanomas tended to occur in male patients, a median age of 58 yr, were generally found on the trunk (64%) and uncommonly associated with chronically sun-damaged (CSD) skin. BRAF L597 melanomas occurred in older patients (median 66 yr), but were associated with CSD skin (extremities or head and neck location - 73.3%, P = 0.001). Twenty-three percent of patients with V600E- and 43% of patients with K601E-mutant melanomas presented with nodal disease at diagnosis compared to just 14% of patients with BRAF wild-type tumors (P = 0.001 and 0.006, respectively). Overall, these mutations represent a significant minority of BRAF mutations, but have distinct clinicopathological phenotypes and clinical behaviors.-
dc.language.isoeng-
dc.subjectBRAF K601E-
dc.subjectBRAF L597-
dc.subjectBRAF mutation-
dc.subjectprimary melanoma-
dc.titleClinicopathological characteristics associated with BRAF(K601E) and BRAF(L597) mutations in melanoma.-
dc.typeJournal Article-
dc.identifier.journaltitlePigment cell & melanoma research-
dc.identifier.affiliationMelbourne University, Parkville, Victoria, Australiaen
dc.identifier.affiliationPeter MacCallum Cancer Centre, East Melbourne, Victoria, Australia-
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationVictorian Melanoma Service, Alfred Hospital, Prahran, Melbourne, Victoria, Australia-
dc.identifier.affiliationSkin and Cancer Foundation, Melbourne, Victoria, Australia-
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.doi10.1111/pcmr.12450-
dc.identifier.orcid0000-0002-4242-1300-
dc.identifier.pubmedid26643848-
dc.type.austinJournal Article-
dc.type.austinResearch Support, Non-U.S. Gov't-
local.name.researcherCebon, Jonathan S
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Jan 7, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.